Brief: Nanomix Partners With Mobility Health
02/09/2022 14:42
Sept 2 (Reuters) - Nanomix Corp NNMX.PK :
* NANOMIX ANNOUNCES AGREEMENT WITH MOBILITY HEALTH TO
CO-DEVELOP A
LAB DEVELOPMENT TEST FOR EVALUATING LEVELS OF COVID-19
CIRCULATING ANTIBODIES
Source text for Eikon: ID:nGNX99f05r
Further company coverage: NNMX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nanomix
See all newsBrief: Nanomix Partners With Mobility Health
Brief: Nanomix Corp Enters Into Distribution Agreement With Bioasia Pte Ltd
Brief: Nanomix announces ISO 134852016 certification for its new facility in San Leandro, CA
Brief: Nanomix Announces Appoints Life Sciences Executive Thomas Schlumpberger As CEO And Member Of The Board Of Directors
Brief: Nanomix Completes 1-For-173 Reverse Stock Split